Researchers analyze the ancestry components in modern and historic VARV genomes
A recent study published in Microbial Genomics analyzed the molecular evolution of the variola virus (VARV).
Study: Analysis of variola virus molecular evolution suggests an old origin of the virus consistent with historical records....
How to Develop a Scalable AAV Process, from Start to Finish
View eBook
Viral vectors are an integral delivery vehicle in modern medicine and are used in everything from oncolytic viruses to vaccines and gene therapies. With two gene therapies approved by regulatory agencies in 2021...
This Legendary Billionaire Biotech Investor Has Remained A … – Forbes
In an exclusive excerpt from For Blood And Money, the untold story of Wayne Rothbaum and the worst trade of his life. But what cost him some $700 million turned out to be the...
Puma Biotechnology to Present at B. Riley Securities’ 3rd Annual … – Business Wire
LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced that Alan H. Auerbach, Chairman, Chief Executive Officer, President and Founder of Puma, will provide an overview of the Company at 11:00 a.m....
The NGS Race Is On: Souped-Up Sequencers Vie for Frontrunner Status
A next-generation sequencing (NGS) novice planning to buy a sequencing instrument might expect to hear a used-car-style sales pitch:
“You want short reads? Sure, we’ve got that. Long reads? Yup, that’s an easy add-on. And...
The Future of Food—CRISPR Crops That Capture Carbon
There is a push to use CRISPR to make agricultural technologies that pull carbon dioxide (CO2) out of the air and store it better in the soil. With the help of CRISPR technology, scientists...
Henry Ford West Bloomfield Hospital now using one-of-a-kind imaging technology for brain tumor surgery
DETROIT (Jan. 12, 2023) – Henry Ford West Bloomfield Hospital has begun using Gleolan®, a one-of-a-kind optical imaging agent that illuminates a common and devastating type of brain tumor called glioma. Gleolan is Food...
Seven Biopharma Trends to Watch in 2023
Industry predictions for 2023 based on a survey of 150-plus biopharma leaders were recently offered by PPD, Thermo Fisher Scientific’s clinical research business. The biopharma leaders’ expectations could be summed up in one word:...
Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease
Jan 12 2023
Pheno Therapeutics Limited., a biotechnology company focused on the discovery and development of small molecule therapeutics that promote remyelination for the treatment of neurological diseases such as multiple sclerosis, announced today it...
Avecho Biotechnology’s Vitamin K injectable gets pre-IND meeting … – Small Caps
Athenex is interested in commercialising Avecho’s TPM-enhanced phytonadione injectable drug.
Avecho Biotechnology (ASX: AVE) has had its TPM-enhanced phytonadione injectable drug presented to the US Food and Drug Administration in a pre-investigational new drug (pre-IND)...
